Mannkind (MNKD) Cash from Operations (2010 - 2026)
Mannkind (MNKD) posted quarterly Cash from Operations of 5365000.0 for Q1 2026, up 15.87% year-over-year from 4630207.74 in Q1 2025, and up 32.58% quarter-over-quarter from 7958000.0 in Q4 2025.
Mannkind (MNKD) Cash from Operations (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has reported Cash from Operations for 17 consecutive years, with 5365000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 15.87% year-over-year to 5365000.0; the TTM figure through Mar 2026 stood at 19267000.0 (down 34.54% YoY), while the FY2025 annual figure was 18255000.0, down 57.06% from the prior year.
- Cash from Operations climbed to 5365000.0 in Q1 2026 per MNKD's latest filing, from 7958000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 23640000.0 in Q3 2025 and bottomed at 31982000.0 in Q2 2022.
- Historically, Cash from Operations has averaged 518588.24 across 5 years, with a median of 2596000.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Operations jumped 1012.37% — and 2025, when it tumbled 195.14%.
- Mannkind's Cash from Operations stood at 2376000.0 in 2022, then surged by 1012.37% to 21678000.0 in 2023, then grew by 4.46% to 22644000.0 in 2024, then plunged by 135.14% to 7958000.0 in 2025, then soared by 32.58% to 5365000.0 in 2026.
- Business Quant data shows MNKD's Cash from Operations at 5365000.0 in Q1 2026, 7958000.0 in Q4 2025, and 23640000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Mannkind | 1.19 Bn | 1.08 Bn | 94.97 Mn | -18.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.37 Mn |
| Jun 30, 2026 | -18.37 Mn |
| Mar 31, 2026 | -5.37 Mn |
| Mar 31, 2026 | -5.37 Mn |
| Dec 31, 2025 | -7.96 Mn |
| Dec 31, 2025 | -7.96 Mn |
| Sep 30, 2025 | 23.64 Mn |
| Sep 30, 2025 | 23.64 Mn |
| Jun 30, 2025 | 8.95 Mn |
| Jun 30, 2025 | 8.95 Mn |
| Mar 31, 2025 | -6.38 Mn |
| Mar 31, 2025 | -6.38 Mn |
| Dec 31, 2024 | 22.64 Mn |
| Dec 31, 2024 | 22.64 Mn |
| Sep 30, 2024 | 9.33 Mn |
| Sep 30, 2024 | 9.33 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | 3.83 Mn |
| Mar 31, 2024 | 6.70 Mn |
| Mar 31, 2024 | 6.70 Mn |